← All stocks

Edwards Lifesciences

EW Net selling
CIK 0001099800 #170 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$3.35M
$0.00 on a plan · $2.95M straight out of an exercise
Sold at will
$400.86K
3 of 6 sales
Net
−$3.35M
−$400.86K against sales at will

By person

18 insiders · 6 transactions
7.9×

Mr. Zovighian holds 7.9 times base salary in stock. $9.43M of shares against $1.19M in salary for 2025.

Salary from the company's own proxy. The shares are what Mr. Zovighian last reported holding, valued at $87.51, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Chopra Daveen
CVP, TMTT, Surgical & IHFM
$2.89M (2) scheduled
−$2.89M
43,926
0.0076%
$3.84M
+49.7%
Bruls Annette
CVP, EMEACLA
$237.91K (1)
−$237.91K
17,984
0.0031%
$1.57M
+122.6%
Markowitz Wayne
CVP, JAPAC
$113.42K (1)
−$113.42K
19,371
0.0034%
$1.70M
+90.2%
Lippis Daniel J.
CVP, TAVR
$54.17K (1) scheduled
−$54.17K
40,034
0.0069%
$3.50M
+69.9%
Dahl Andrew M.
SVP, Corporate Controller
$49.53K (1)
−$49.53K
14,615
0.0025%
$1.28M
+171.5%
Wood Larry L
Global President TAVR & Surg
206,900
0.0359%
$18.11M
−7.5%
BOBO DONALD E JR
CVP,Strategy/Corp Development
121,409
0.0211%
$10.62M
−36.2%
Zovighian Bernard J
CEO
107,761
0.0187%
$9.43M
+56.6%
Mistras Theodora
CVP, Chief Financial Officer
99,920
0.0173%
$8.74M
VALERIANI NICHOLAS J
Director
84,423
0.0146%
$7.39M
+14.5%
Ullem Scott B.
CVP, Chief Financial Officer
46,740
0.0081%
$4.09M
+52.9%
STONE HEISZ LESLIE
Director
34,199
0.0059%
$2.99M
+13.9%
LAVIOLETTE PAUL A
Director
17,552
0.0030%
$1.54M
+62.9%
Davis Leslie C.
Director
9,834
0.0017%
$860.57K
+221.9%
Feinberg David T
Director
9,087
0.0016%
$795.20K
+293.7%
LORANGER STEVEN R
Director
8,997
0.0016%
$787.33K
Sequeira Ramona
Director
6,779
0.0012%
$593.23K
GALLAHUE KIERAN
Director
4,315
0.0007%
$377.61K
Insider
Date
Role
Action
Shares
Price
Amount
Lippis Daniel J.
11 Sep 2026
CVP, TAVR
Sold after exercise
619
$87.51
$54.17K
Dahl Andrew M.
31 Aug 2026
SVP, Corporate Controller
Sell
544
$91.06
$49.53K
Bruls Annette
28 Aug 2026
CVP, EMEACLA
Sell
2,644
$89.98
$237.91K
Markowitz Wayne
26 Aug 2026
CVP, JAPAC
Sell
1,240
$91.47
$113.42K
Chopra Daveen
26 Aug 2026
CVP, TMTT, Surgical & IHFM
Sold after exercise
30,646
$90.99
$2.79M
Chopra Daveen
26 Aug 2026
CVP, TMTT, Surgical & IHFM
Sold after exercise
1,154
$91.76
$105.89K

What was left out

Form 4 filings counted 8
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 33,993
History held since 29 Aug 2016